CD274 and lung carcinoma: Patient-derived ex vivo expanded NK cells successfully killed lung cancer cells, secreted IFN-γ thus re-activating immunosuppressed tumor infiltrated lymphocytes and increased PD-L1 expression on tumor cells, leading to a change in anti-PD-L1 response and an anti-PD-L1 second-hit strategy [97].